The endosymbiotic bacterium Wolbachia induces resistance to dengue virus in Aedes aegypti.
Bian G, Xu Y, Lu P, Xie Y, Xi Z. · 2010
Read The endosymbiotic bacterium Wolbachia induces resistance to dengue virus in Aedes aegypti. by Bian G, Xu Y, Lu P, Xie Y, Xi Z. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2848556.txt.
Introduction
Bian, Xu, Lu, Xie, and Xi tested in 2010 whether Wolbachia, a bacterium living inside mosquito cells, can block dengue virus in Aedes aegypti, the main dengue carrier. Dengue threatens billions of people and has no vaccine or cure, so stopping the mosquito matters. Because Wolbachia and the virus crowd into the same tissues, the team compared infected and uninfected mosquitoes after dengue exposure.
Wolbachia sharply cut viral growth and spread inside the mosquitoes. Two weeks after infection it fully blocked transmission in well over a third of the infected mosquitoes tested. Infected mosquitoes also showed livelier baseline immunity and lived longer. The results support spreading Wolbachia through wild mosquito populations as a dengue control strategy.
Catalog record
| CREATOR | Bian G, Xu Y, Lu P, Xie Y, Xi Z. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The Endosymbiotic Bacterium Wolbachia Induces Resistance to Dengue Virus in Aedes aegypti By Guowu Bian, Yao Xu, Peng Lu, Yan Xie, Zhiyong Xi, David S. Schneider Published in: PLoS Pathogens DOI: 10.1371/journal.ppat.1000833 ABSTRACT Genetic strategies that reduce or block pathogen transmission by mosquitoes have been proposed as a means of augmenting current control measures to reduce the growing burden of vector-borne diseases. The endosymbiotic bacterium Wolbachia has long been promoted as a potential vehicle for introducing disease-resistance genes into mosquitoes, thereby making them refractory to the human pathogens they transmit. Given the large overlap in tissue distribution and intracellular localization between Wolbachia and dengue virus in mosquitoes, we conducted experiments to characterize their interactions. Our results show that Wolbachia inhibits viral replication and dissemination in the main dengue vector, Aedes aegypti. Moreover, the virus transmission potential of Wolbachia-infected Ae. aegypti was significantly diminished when compared to wild-type mosquitoes that did not harbor Wolbachia. At 14 days post-infection, Wolbachia completely blocked dengue transmission in at least 37.5% of Ae. aegypti mosquitoes. We also observed that this Wolbachia-mediated viral interference was associated with an elevated basal immunity and increased longevity in the mosquitoes. These results underscore the potential usefulness of Wolbachia-based control strategies for population replacement. INTRODUCTION Dengue fever and its associated condition, the highly lethal dengue hemorrhagic fever, are emerging globally as the most important arboviral diseases currently threatening human populations. Approximately 2.5 billion people are at risk of contracting dengue-associated disease, with an estimated 50–100 million cases occurring each year [1]. Dengue virus (DENV) is transmitted to humans by aedine mosquitoes, primarily Aedes aegypti and, to a lesser extent, Aedes albopictus. At present, no treatment or vaccine is available for dengue fever; thus, vector control is currently the primary intervention tool. One such method is population replacement, in which natural Ae. aegypti populations would be replaced with modified populations that are unable to transmit DENV. Recently, significant progress has been made in producing Ae. aegypti strains that are refractory to DENV [2],[3] and in exploring transgene drivers for population replacement [4],[5]. One of the most promising transgene drivers is a maternally transmitted Gram-negative endosymbiotic bacterium, Wolbachia. Significantly, Wolbachia is able to spread rapidly within an uninfected Ae. aegypti laboratory population after the population has been seeded with infected females [6]. Wolbachia induces a reproductive abnormality known as cytoplasmic incompatibility (CI), which results in early embryo death when a Wolbachia-infected male has mated with a female that is uninfected or harboring a different Wolbachia type. Since uninfected males can successfully mate with infected females, Wolbachia and any gene it carries can spread quickly in a population. Two control approaches using Wolbachia-based population replacement have been proposed: One potential approach involves linking a transgene to Wolbachia. The mosquito's vectorial capacity is reduced as the transgene is carried by Wolbachia into the target population. The second approach utilizes the ability of Wolbachia itself to modify both the sexual reproduction and vectorial capacity of the host. For example, after mosquitoes are fed an infectious blood meal, a period of 7–14 days (depending on environmental and intrinsic factors) is required before the mosquitoes are able to transmit DENV to a new host [7],[8]. One strain of Wolbachia, called popcorn, has been shown to reduce the longevity of mosquitoes, causing the insects to die before they can transmit viruses [9],[10]. Wolbachia, introduced into wild vector populations, will inevitably encounter DENV, given large overlap in tissue distribution and intracellular localization of these two microorganism [8],[11]. However, at present it is still unclear how Wolbachia and DENV interact in the mosquito. Recent studies in Drosophila have shown that Wolbachia can confer resistance to diverse RNA viruses and protect flies from virus-induced mortality [12],[13]. Two groups have independently reported that Wolbachia significantly reduces the infection level of the Drosophila C virus, a member of the Dicistroviridae, in different lines of D. melanogaster. When compared to flies cured of Wolbachia infection, those with an active Wolbachia infection showed a significantly delayed mortality induced by Drosophila C virus infection. A similar antiviral effect was also observed in Wolbachia-infected flies challenged with cricket paralysis virus (Dicistroviridae), Nora virus (a new picorna-like virus family) and flock house virus (Nodaviridae). Since Drosophila C virus and DENV are both single-stranded positive-sense RNA viruses, these findings strongly support the existence of an overarching mechanism that is also applicable to Wolbachia-DENV interactions in their mosquito hosts. Although Ae. aegypti is not naturally infected by Wolbachia, infection has been achieved by transfection with wAlbB, an infection type of Wolbachia from Ae. albopictus, by means of embryonic microinjection [6]. wAlbB is able to induce a complete CI in Ae. aegypti, and this phenotype can be reversed by tetracycline treatment. Moreover, it has a 100% maternal transmission rate, with no fitness costs observed [6]. Since it was introduced, this infection has been stably maintained in Ae. aegypti for about 6 years in the laboratory. Our previous studies have shown that the mosquito's endogenous bacterial flora boost the basal level of immunity in the mosquito and that their removal leads to an increase in the level of dengue infection [14]. In the Drosophila S2 cell line, we also found that Wolbachia activates immune signaling pathways and induces the expression of antimicrobial peptide genes [15]. In Ae. egypti, we have further demonstrated that the anti-bacterial defense responses can control dengue infection [14]. Here, we have asked whether Wolbachia, a component of the mosquito's microbial flora, can suppress DENV in Ae. aegypti. We found that Wolbachia can indeed inhibit DENV infection in Ae. Aegypt, and this inhibition was associated with an elevated immune response and an increase in the mosquito's longevity. RESULTS Wolbachia-induced suppression of DENV replication in the mosquito midgut To characterize the effect of Wolbachia on DENV infection in Ae. aegypti, we compared DENV dynamics within the mosquito between the original wild-type Waco strain (Wolbachia-free) and the Waco-derived WB1 strain (Wolbachia-transfected). Mosquitoes were fed sheep blood containing the New Guinea C strain of DENV serotype 2 (DENV-2), with viral titers of 2.0×107 PFU/ml. Using an indirect fluorescent antibody assay (IFA) performed on head squashes at 14 days after the infectious meal, we had previously confirmed that this virus titer resulted in a >90% infection rate in experimentally infected Waco females. The number of copies of DENV-2 genomic RNA was monitored in mosquito midguts by quantitative reverse transcriptase PCR (qRT-PCR) at 3, 6, 9, 12, 15 and 18 days post-infection. Five biological replicates were used for each time point. The number of copies of DENV-2 RNA in the WB1 strain was significantly lower than that in Waco strain at all five time points, with the exception of Day 9 (Mann-Whitney U test, P<0.05) (Figure 1). On Days 3 and 6, DENV was detectable in only one of ten WB1 samples, whereas all the Waco samples were positive for dengue infection. On Day 9, the median viral titer in the WB1 strain reached 9.1×103 genome copies per midgut, whereas the median titer in the Waco strain was 2.4×106 genome copies per midgut; however, this difference was not statistically significant. RNA copy numbers remained at a high level in the midguts of Waco strain mosquitoes from Day 9 to 18. [Figure: Inhibition of dengue